[Recombinant interleukin-2].
Tarentini Trojani
F
F
D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
D007376:Interleukin-2
L'interleuchina-2 ricombinante.